Cardiff-based corporate finance boutique Gambit has advised on the Spanish acquisition of laser eye surgery specialist Eye Hospitals Group in a deal that could be worth nearly £20m.
Gambit acted for Spanish firm Clinica Baviera, which is listed on the Madrid Stock Market, on its acquisition with has seen an initial consideration of £10m which could rise to more than £19m based on future trading performance.
Read More: Development bank exceeds jobs target but big fall in equity deals
Read More: New chair of the Development Bank of Wales
The Eye Hospitals Group, which operates under the its Optimax and Ultralase brands, has a clinic in Cardiff which offers specialised vision correction services, addressing conditions such as short-sightedness, long-sightedness, astigmatism and presbyopia.
Optimax was one of the of the first private clinics in the 海角视频 to offer laser eye surgery.
Clínica Baviera, has a current market capitalisation of more than £250m. The acquisition represents its first move into the 海角视频 marketplace and forms part of a Europe-wide organic and acquisition growth strategy.
Optimax, the Eye Hospitals Group’s biggest brand, currently has 19 clinics located in key cities throughout the 海角视频 from which it provides refractive surgery services and other ophthalmological treatments, assisted by a team of more than 130 personnel, with revenues of around £14.5m.
Most Read
Gambit Corporate Finance, led by partners Frank Holmes and Sam Forman, assisted Clinica Baviera with the negotiation of the deal value, structure and transaction process.
Eduardo Baviera, Co-founder and chief executive of Clinica Baviera, said “We are excited in entering the 海角视频 market in order to continue with Clinica Baviera’s strategic growth plans. The Opimax brand is well respected and the pioneer of laser eye surgery in the 海角视频. I would like to thank Gambit Corporate Finance for its support in executing and managing the cross-border transaction.”
Mr Holmes said: “It has been a pleasure to work with the Clinica Baviera team and assist it accessing the 海角视频 ophthalmic market via this strategic acquisition which will serve as the platform for future growth and geographic expansion.
"Our ability to engage across borders has become a key attraction for clients entering the 海角视频 or in the opposite direction selling and acquiring companies overseas”
Mr Forman added “This is an important strategic acquisition for Clinica Baviera and adds to its existing market leading positions in Spain, Germany and Italy. As part of CFI (Corporate Finance International), this acquisition demonstrates the value Gambit can add in accessing targets and buyers on a global basis.”